Two Sigma Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Two Sigma Investments’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,400	Closed	-$303K	–	3655
2018 Q3	$303K	Buy	+2,400	New	+$254K	﹤0.01%	2768
2017 Q3	–	Sell	-12,000	Closed	-$1.45M	–	3307
2017 Q2	$1.45M	Buy	12,000 +10,000	+500%	+$1.16M	0.01%	1649
2017 Q1	$226K	Buy	+2,000	New	+$233K	﹤0.01%	2678
2016 Q4	–	Sell	-8,000	Closed	-$1.32M	–	3606
2016 Q3	$1.32M	Hold	8,000	–	–	﹤0.01%	1765
2016 Q2	$1.14M	Buy	+8,000	New	+$1.17M	﹤0.01%	1635

Two Sigma Investments's ICPT Position: Q4 2023 in Review

Two Sigma Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 84,718 shares — an estimated $1.57M sold.

Two Sigma Investments first reported a position in ICPT in Q4 2013 and held it in 26 quarters. The position peaked at $37.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Two Sigma Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Two Sigma Investments sold 84,718 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.57M.
Two Sigma Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 26 quarters.
Two Sigma Investments's Intercept Pharmaceuticals, Inc. position peaked at $37.3M in Q4 2019.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.